MARKET UPDATES :
Malaysian Biotechnology Corp (BiotechCorp) aims to reap RM2 billion in revenue from 248 BioNexus-status companies in 2015, its Chief Executive Officer, Datuk Dr Mohd Nazlee Kamal said.These companies generated revenue of RM1.4 billion in 2014 from RM1.169 billion in 2013.BioNexus is a special status awarded to qualified international and Malaysian biotech companies that qualify for fiscal incentives, grants and guarantees administered by BiotechCorp.
STOCK RECOMMENDATION :
BUY V.S INDUSTRY ABOVE 2.860 TARGET 2.900 2.960 SL 2.800
Malaysian Biotechnology Corp (BiotechCorp) aims to reap RM2 billion in revenue from 248 BioNexus-status companies in 2015, its Chief Executive Officer, Datuk Dr Mohd Nazlee Kamal said.These companies generated revenue of RM1.4 billion in 2014 from RM1.169 billion in 2013.BioNexus is a special status awarded to qualified international and Malaysian biotech companies that qualify for fiscal incentives, grants and guarantees administered by BiotechCorp.
STOCK RECOMMENDATION :
BUY V.S INDUSTRY ABOVE 2.860 TARGET 2.900 2.960 SL 2.800
No comments:
Post a Comment